Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 30 - Any |
| Updated: | 7/7/2017 |
| Start Date: | June 2014 |
| End Date: | June 2018 |
| Contact: | Janice Sung, MD |
| Phone: | 646-888-5423 |
The purpose of this study is to determine whether ultrasound or Digital breast tomosynthesis
(DBT) detects more cancers and to compare the types of cancers detected on ultrasound and
DBT.
(DBT) detects more cancers and to compare the types of cancers detected on ultrasound and
DBT.
Inclusion Criteria:
- Any women scheduled for screening WBUS and a screening FFDM on the same day or within
the following 30 days of each other.
Exclusion Criteria:
- Age < 30 years old
- Male patients
- Patients with any clinical symptoms (palpable mass, nipple discharge, etc)
- Patients with known cancer
- Patients with any breast surgery or biopsy within 90 days prior to the study
- Patients with breast implants
- Patients pregnant or lactating
We found this trial at
1
site
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Principal Investigator: Janice Sung, MD
Phone: 646-888-5423
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
